Christian P. Pallasch

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Correction: Innovative Exercise in Routine Cancer Care: Insights from Eight Years of Integrated Oncological Exercise Therapy (OTT).

Correction: Innovative Exercise in Routine Cancer Care: Insights from Eight Years of Integrated Oncological Exercise Therapy (OTT).

Journal: Sports medicine - open
Published: June 15, 2026

Protocol for assessing antibody-mediated cellular phagocytosis of lymphoma cells by human and murine macrophages in vitro.

Protocol for assessing antibody-mediated cellular phagocytosis of lymphoma cells by human and murine macrophages in vitro.

Journal: STAR protocols
Published: June 27, 2025

Innovative Exercise in Routine Cancer Care: Insights from Eight Years of Integrated Oncological Exercise Therapy (OTT).

Innovative Exercise in Routine Cancer Care: Insights from Eight Years of Integrated Oncological Exercise Therapy (OTT).

Journal: Sports medicine - open
Published: January 02, 2025

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

Journal: Cancer cell
Published: August 25, 2024

Macrophages are activated toward phagocytic lymphoma cell clearance by pentose phosphate pathway inhibition.

Macrophages are activated toward phagocytic lymphoma cell clearance by pentose phosphate pathway inhibition.

Journal: Cell reports. Medicine
Published: February 29, 2024

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.

Journal: Nature communications
Published: October 23, 2023

CXCL10 deficiency limits macrophage infiltration, preserves lung matrix, and enables lung growth in bronchopulmonary dysplasia.

CXCL10 deficiency limits macrophage infiltration, preserves lung matrix, and enables lung growth in bronchopulmonary dysplasia.

Journal: Inflammation and regeneration
Published: May 23, 2023

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy.

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy.

Journal: Basic research in cardiology
Published: October 31, 2022

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.

Journal: Nature communications
Published: August 24, 2022

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ.

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ.

Journal: Communications biology
Published: August 21, 2022

COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility.

COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility.

Journal: Biomedicines
Published: January 28, 2022

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.

Journal: HemaSphere
Published: January 24, 2022
Showing 1-12 of 43

Last Updated: 09/26/2026